Wolinsky JS - Search Results

1

Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.

Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Ann Neurol. 1995 Apr;37(4):546-9. doi: 10.1002/ana.410370418. Ann Neurol. 1995. PMID: 7717692

2

Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report.

Nath A, Kerman RH, Novak IS, Wolinsky JS. Nath A, et al. Among authors: wolinsky js. Neurology. 1990 Apr;40(4):581-3. doi: 10.1212/wnl.40.4.581. Neurology. 1990. PMID: 2138717

3

Proton magnetic resonance spectroscopy in multiple sclerosis.

Wolinsky JS, Narayana PA, Fenstermacher MJ. Wolinsky JS, et al. Neurology. 1990 Nov;40(11):1764-9. doi: 10.1212/wnl.40.11.1764. Neurology. 1990. PMID: 2172865

4

Antibody response to rubella virus structural proteins in multiple sclerosis.

Nath A, Wolinsky JS. Nath A, et al. Among authors: wolinsky js. Ann Neurol. 1990 May;27(5):533-6. doi: 10.1002/ana.410270513. Ann Neurol. 1990. PMID: 2360794

5

Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis.

Nath A, Wolinsky JS, Kerman RH. Nath A, et al. Among authors: wolinsky js. J Neuroimmunol. 1989 Apr;22(2):143-8. doi: 10.1016/0165-5728(89)90045-3. J Neuroimmunol. 1989. PMID: 2925842 Clinical Trial.

6

Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients.

Kerman RH, Wolinsky JS, Nath A, Sears ES Jr. Kerman RH, et al. Among authors: wolinsky js. J Neuroimmunol. 1988 Jul;18(4):325-31. doi: 10.1016/0165-5728(88)90053-7. J Neuroimmunol. 1988. PMID: 2968363 Clinical Trial.

7

Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

McCarthy M, Lovett A, Kerman RH, Overstreet A, Wolinsky JS. McCarthy M, et al. Among authors: wolinsky js. J Virol. 1993 Feb;67(2):673-81. doi: 10.1128/JVI.67.2.673-681.1993. J Virol. 1993. PMID: 7678302 Free PMC article.

8

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.

Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Khan M, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Neurology. 1996 Jun;46(6):1633-8. doi: 10.1212/wnl.46.6.1633. Neurology. 1996. PMID: 8649562

9

Multiple sclerosis: clinical presentation, diagnosis and treatment.

Brod SA, Lindsey JW, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Am Fam Physician. 1996 Sep 15;54(4):1301-6, 1309-11. Am Fam Physician. 1996. PMID: 8816574 Review.

10

Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Mult Scler. 1997 Feb;3(1):1-7. doi: 10.1177/135245859700300101. Mult Scler. 1997. PMID: 9160341 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters